This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rare Lung Disease Community Empowered Through Connectivity

Unique educational and support group toolkit -- a vital resource for IPF community

TORONTO, Feb. 27, 2013 /CNW/ - To mark the sixth international Rare Disease Day, the Canadian Pulmonary Fibrosis Foundation (CPFF) has launched its new website, The online hub serves as a communal resource for patients and individuals affected by idiopathic pulmonary fibrosis (IPF), a rare, progressive and uniformly fatal lung disease that affects an estimated 5,000 to 8,000 Canadians.  The new website enables IPF patients, their families, and caregivers to access information and resources about all stages of the disease, and offers support tools for use at the community level.

Rare disease, common challenges

Hundreds of patient organizations around the world will unite tomorrow ( February 28) to observe international Rare Disease Day by participating in awareness-raising activities. According to the Canadian Organization for Rare Disease (CORD), 1 in 12 Canadians have a rare disorder, and many others are affected or at risk, but remain undiagnosed and unaware.  People affected by rare disease face challenges such as delays in obtaining a diagnosis, misdiagnosis, psychological burden and lack of support service for the patient and family.  It is vital to raise awareness for those stricken by rare diseases to ensure that they are provided with the tools, resources and support required to overcome common obstacles in their life.

"Given the fast changing landscape for the treatment of IPF in Canada, it is crucial for patients to stay connected and current on new treatment options available to them, and be able to access the best possible care to help them fight their disease," said Robert Davidson, president and founder of the CPFF.  "Up until now, the lack of available tools and resources has left many within the IPF community feeling helpless and alone.  Connectivity can be very empowering, especially for patients who have difficulty with their mobility."

New resources breakthrough isolation

To address the needs of the IPF patient community, the new CPFF website includes an important new section on advocacy and support, which features the IPF Patient Education and Support Group Toolkit.  This new resource developed to help patients, their family members and caregivers build and manage new patient support groups throughout Canada, will assist in connecting and strengthening the IPF community.  Comprised of six modules and other supporting documents, the toolkit will assist individuals interested in planning and executing IPF patient support groups in their communities, either in person or online.

"The IPF toolkit is an exciting and unique development for those affected by this devastating disease," said Dr. Meena Kalluri, respirologist, University of Alberta, who helped develop the resource.  "It's the first of its kind for the IPF community in Canada, and enables individuals affected by IPF to connect quickly and easily to access the necessary information and support."

Led by a steering committee comprised of IPF specialists, including Dr. Kalluri, as well as members of the CPFF, and the Ontario Lung Association, the development of the IPF Patient Education and Support Group Toolkit was made possible through a grant from InterMune Canada Inc.  With the addition of a new community forum on the CPFF website, members of the IPF community now have a variety of ways to connect with others affected by this devastating disease to share stories and information, and to get support and resources to help them achieve the best possible outcomes and quality of life.   Through the new website, patients and caregivers can find specialized clinics and healthcare providers across Canada, as well as information about community events, volunteer and fundraising opportunities and updates on research and new treatment options.

"It is vital for people diagnosed with a rare disease like IPF to stay connected with the patient community - it's a lifeline to helpful resources and support," added Davidson.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs